Shopping Cart
Remove All
Your shopping cart is currently empty
Imalumab (Alias: BAX69, BAX 69, Anti-Human MIF Recombinant Antibody)
Catalog No. T76789 Copy Product Info
Purity: 95%
🥰Excellent
Imalumab (BAX69) is a recombinant humanised monoclonal antibody that targets and inhibits MIF (macrophage inhibitory factor), exhibiting anticancer activity. It is applicable for advanced solid tumours such as ovarian cancer and non-small cell lung cancer.
Imalumab
Copy Product Info🥰Excellent
Catalog No. T76789
Alias BAX69, BAX 69, Anti-Human MIF Recombinant Antibody
Imalumab (BAX69) is a recombinant humanised monoclonal antibody that targets and inhibits MIF (macrophage inhibitory factor), exhibiting anticancer activity. It is applicable for advanced solid tumours such as ovarian cancer and non-small cell lung cancer.
Imalumab
Cas No. 1430205-07-4
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $438 | - | In Stock | |
| 5 mg | $1,320 | - | In Stock | |
| 10 mg | $2,120 | - | In Stock | |
| 25 mg | $3,130 | - | In Stock | |
| 50 mg | $4,230 | - | In Stock |
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:96.5% (SDS-PAGE); 96.3% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Imalumab (BAX69) is a recombinant humanised monoclonal antibody that targets and inhibits MIF (macrophage inhibitory factor), exhibiting anticancer activity. It is applicable for advanced solid tumours such as ovarian cancer and non-small cell lung cancer. |
| In vitro | Imalumab specifically binds to oxidized macrophage migration inhibitory factor (oxMIF) in Parazacco spilurus subsp. spilurus, thereby interfering with its downstream signaling pathways. Imalumab can induce antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP), and is capable of inducing cell lysis in Homo sapiens peripheral blood mononuclear cells (PBMCs) with an EC50 of 0.7-39.2 nM[[2]. |
| In vivo | In the BALB/c mouse model, the terminal half-life of Imalumab (5 mg/kg, intravenous injection) was 37.4 hours [2]. |
| Synonyms | BAX69, BAX 69, Anti-Human MIF Recombinant Antibody |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | MIF |
| Molecular Weight | 144.64 kDa |
| Cas No. | 1430205-07-4 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Imalumab | purchase Imalumab | Imalumab cost | order Imalumab | Imalumab in vivo | Imalumab in vitro | Imalumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.